机构:[1]Department of Neurology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.[2]The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.[3]Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, China.[4]Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China.[5]Department of Neurology, Linyi People's Hospital, Shandong, China.[6]Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.[7]Department of Neurology and Neuroscience, Shenyang First People's Hospital, Liaoning, China.[8]Department of Neurointervention, Zhangzhou affiliated Hospital of Fujian Medical University, Fujian, China.[9]Department of Neurology, Nanyang Central Hospital, Nanyang, China.[10]Department of Neurology, The First Hospital of Jilin University, Jilin, China.[11]Department of Neurology, Zhengzhou Central Hospital, Zhengzhou, China.[12]Department of Neurosurgery, Liaocheng People's Hospital, Shandong, China.[13]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.神经科系统神经外科首都医科大学宣武医院[14]Department of Interventional Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.江苏省人民医院[15]School of Public Health, Peking University, Beijing, China.
第一作者机构:[1]Department of Neurology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.[2]The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.
通讯作者:
通讯机构:[2]The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing, China.[3]Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, China.[15]School of Public Health, Peking University, Beijing, China.[*1]Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, No. 1, Shuaifuyuan, Wangfujing, Beijing 100730, China.[*2]The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, No. 118, Guang'anmen Inner Street, Beijing 100053, China
推荐引用方式(GB/T 7714):
Ye Qing,Zhai Feifei,Chao Baohua,et al.Rates of intravenous thrombolysis and endovascular therapy for acute ischaemic stroke in China between 2019 and 2020.[J].LANCET REGIONAL HEALTH-WESTERN PACIFIC.2022,21:doi:10.1016/j.lanwpc.2022.100406.
APA:
Ye Qing,Zhai Feifei,Chao Baohua,Cao Lei,Xu Yun...&Wang Long-De.(2022).Rates of intravenous thrombolysis and endovascular therapy for acute ischaemic stroke in China between 2019 and 2020..LANCET REGIONAL HEALTH-WESTERN PACIFIC,21,
MLA:
Ye Qing,et al."Rates of intravenous thrombolysis and endovascular therapy for acute ischaemic stroke in China between 2019 and 2020.".LANCET REGIONAL HEALTH-WESTERN PACIFIC 21.(2022)